Current views on the genetic landscape and management of variant acute promyelocytic leukemia
Abstract Acute promyelocytic leukemia (APL) is characterized by the accumulation of promyelocytes in bone marrow. More than 95% of patients with this disease belong to typical APL, which express PML-RARA and are sensitive to differentiation induction therapy containing all-trans retinoic acid (ATRA)...
Main Authors: | Xiang Zhang, Jiewen Sun, Wenjuan Yu, Jie Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | Biomarker Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40364-021-00284-x |
Similar Items
-
Acute promyelocytic leukemia, hypogranular variant: a rare presentation
by: Kafil Akhtar, et al.
Published: (2011-04-01) -
Molecular basis for the diagnosis and treatment of acute promyelocytic leukemia
by: Sarah Cristina Bassi, et al.
Published: (2012-01-01) -
Cytogenetics and FISH negative cryptic acute promyelocytic leukemia with CD56 expression
by: Jhansi Rani Arumugam, et al.
Published: (2021-01-01) -
ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: A SINGLE CENTRE EXPERIENCE FROM TURKEY
by: Tekin Aksu
Published: (2018-07-01) -
Non‐acute promyelocytic leukemia variant, acute myeloid leukemia with translocation (11;17)
by: Rahaf Altahan, et al.
Published: (2019-03-01)